Table 3.
Item 1 | Period | Treatment 2 | SEM | p-Values | ||||
---|---|---|---|---|---|---|---|---|
CON | PM1 | PM2 | Treatment | Time | Treatment × Time | |||
Energy metabolism | ||||||||
GLU, mmol/L | І | 3.3 | 3.3 | 3.4 | 0.4 | 0.67 | 0.35 | 0.90 |
ІІ | 2.8 | 2.9 | 2.8 | 0.3 | 0.74 | 0.94 | 0.03 | |
Insulin, mIU/mL | І | 17.5 | 20.4 | 20.1 | 5.7 | 0.45 | 0.34 | 0.35 |
ІІ | 17.6 | 18.4 | 20.4 | 4.7 | 0.50 | 0.78 | 0.79 | |
Glucagon, pg/mL | І | 151.2 | 151.3 | 153.0 | 26.6 | 0.96 | 0.49 | 0.40 |
ІІ | 182.4 | 174.0 | 172.4 | 23.1 | 0.63 | 0.30 | 0.88 | |
BHBA, mmol/L | І | 0.4 | 0.6 | 0.5 | 0.2 | 0.23 | 0.24 | 0.54 |
ІІ | 0.5 | 0.7 | 0.7 | 0.2 | 0.11 | 0.68 | 0.08 | |
TG, mmol/L | І | 0.3 | 0.3 | 0.3 | <0.1 | 0.73 | 0.13 | 0.14 |
ІІ | 0.3 | 0.3 | 0.3 | <0.1 | 0.97 | 0.23 | 0.25 | |
Liver function | ||||||||
GPT, U/L | І | 27.8 a | 25.9 a | 20.0 b | 3.4 | <0.01 | 0.18 | <0.01 |
ІІ | 26.3 | 25.9 | 27.3 | 3.4 | 0.71 | 0.56 | 0.10 | |
AST, U/L | І | 73.8 | 80.1 | 70.3 | 13.4 | 0.32 | 0.85 | 0.99 |
ІІ | 91.0 a | 81.8 a,b | 70.4 b | 12.5 | 0.01 | 0.98 | 1.00 | |
ALP, U/L | І | 47.7 | 49.1 | 48.7 | 6.9 | 0.95 | 0.43 | 0.15 |
ІІ | 53.1 | 59.4 | 55.8 | 10.2 | 0.55 | 0.98 | 0.82 | |
TP, g/L | І | 65.3 b | 62.6 b | 70.6 a | 4.2 | <0.01 | 0.96 | 0.39 |
ІІ | 67.1 | 67.3 | 73.4 | 6.7 | 0.08 | 0.83 | 0.85 | |
ALB, g/L | І | 33.8 | 33.2 | 33.8 | 2.3 | 0.80 | 0.76 | 0.31 |
ІІ | 33.9 | 35.8 | 34.7 | 1.8 | 0.08 | 0.84 | 0.68 | |
GLB, g/L | І | 30.4 b | 31.0 b | 35.3 a | 4.5 | 0.05 | 0.37 | 0.32 |
ІІ | 33.2 | 31.5 | 34.4 | 5.3 | 0.54 | 0.98 | 0.91 | |
Oxidative stress | ||||||||
T-AOC, U/mL | І | 24.9 b | 29.2 a | 29.8 a | 2.0 | <0.01 | 0.15 | 0.93 |
ІІ | 22.4 b | 25.3 a | 25.9 a | 2.3 | 0.01 | 0.07 | 0.19 | |
MDA, nmol/mL | І | 5.1 | 5.6 | 4.7 | 2.3 | 0.75 | 0.38 | 0.24 |
ІІ | 5.1 a | 4.4 a,b | 4.0 b | 0.6 | 0.02 | 0.21 | 0.92 | |
SOD, U/mL | І | 50.5 b | 50.8 b | 53.8 a | 2.1 | <0.01 | 0.15 | 0.85 |
ІІ | 54.0 b | 54.7 b | 57.0 a | 2.1 | <0.01 | 0.96 | 0.67 | |
GSH-Px, U/mL | І | 317.1 | 328.5 | 316.8 | 52.1 | 0.86 | 0.01 | 0.63 |
ІІ | 329.3 | 313.3 | 332.3 | 34.2 | 0.71 | 0.19 | 0.28 | |
Immunity parameters | ||||||||
IgA, μg/mL | І | 240.4 | 260.6 | 260.8 | 28.0 | 0.43 | 0.59 | 0.02 |
ІІ | 241.8 b | 227.3 b | 296.5 a | 48.1 | 0.03 | 0.90 | 0.41 | |
IgG, mg/mL | І | 8.2 | 7.5 | 9.0 | 1.0 | 0.06 | 0.53 | 0.01 |
ІІ | 8.1 b | 7.8 b | 10.1 a | 1.4 | 0.01 | 0.41 | 0.17 | |
IgM, mg/mL | І | 2.3 b | 2.4 b | 2.9 a | 0.3 | 0.01 | 0.01 | 0.02 |
ІІ | 2.5 b | 2.8 b | 3.3 a | 0.5 | 0.03 | <0.01 | 0.75 | |
TNF-α, ng/L | І | 531.8 | 508.4 | 515.9 | 52.4 | 0.63 | 0.33 | 0.38 |
ІІ | 545.4 a,b | 515.2 b | 593.4 a | 47.9 | 0.04 | 0.09 | 0.11 |
a,b Least squares means within a row with different superscripts differ significantly (p ≤ 0.05). 1 GLU: glucose; BHBA: β-hydroxybutyric acid; TG: triglyceride; GPT: glutamic-pyruvic transaminase; AST: aspartate aminotransferase; ALP: alkaline phosphatase; TP: total protein; ALB: albumin; GLB: globulin; T-AOC: total antioxidant capacity; MDA: malonaldehyde; SOD: superoxide dismutase; GSH-Px: glutathione peroxidase; IgA: immune globulin A; IgG: immune globulin G; IgM: immune globulin M; and TNF-α: anti-tumor necrosis factor -α. 2 The CON group had non-PM silage diets during period I and period II; the PM1 group had 4.5 and 13.5% PM silage diets during period I and period II, respectively; and the PM2 group had 9 and 18% PM silage diets during period I and period II, respectively.